CSF3 and Decreased total neutrophil count: Because patients under chemotherapy as frontline treatment are at risk of developing neutropenia (Blayney and Schwartzberg, 2022), G-CSF is often administered to foster neutrophil production and their egress from the bone marrow (Mehta et al, 2015), (Lambertini et al, 2015).